Lundbeck.
Danish pharmaceutical company
- Reports this week
- 4
- Active events
- 2
- Connections
- 88
What's happening
Active this week
Earlier this month
One to three months ago
-
European Commission granted orphan designation for Lundbeck's drug asedebart in the EU market.Some support3 reports
-
The FDA granted Fast Track designation to Lu AH69593, a treatment associated with Lundbeck.Some support1 report
-
Lundbeck is leading a global Phase III trial, the DEEp OCEAN Trial, which is evaluating an investigational molecule.Some support6 reports
Gone quiet
No new reports in 90+ days-
Lundbeck presents data at EAN Congress 2026.Some support2 reports
-
A study was presented at a meeting in Chicago involving Lundbeck and its R&D head, Johan Luthman.Some support1 report
-
UCB, Eisai, Lundbeck, and GW Pharmaceuticals are identified as key players in a market supported by supportive FDA policies.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Lundbeck this week
News at the entities that move Lundbeck most-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves Lundbeck
-
European Commission StructuralA European Commission summit focused on strategic cooperation, minerals, and pivoting away from the United States toward the EU.Moves Lundbeck
-
Food and Drug Administration StructuralIn 2007, CBS broadcast featured Andrews, Cordes, and Couric criticizing the Food and Drug Administration's problems.Moves Lundbeck
-
Illinois StructuralPritzker enhanced the state's film tax credit program in Illinois.Moves Lundbeck
-
Greater Boston StructuralBoston is a submarket within Greater Boston, and Watertown is located near Cambridge and Greater Boston.Moves Lundbeck
-
Chicago Shared contextThe Chicago City Council requires council approval for appointments.Moves Lundbeck
Connections
The 12 strongest of 88, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Charl van Zyl Structural
Charl van Zyl holds the position of CEO at Lundbeck.
-
Greater Boston Structural
Lundbeck is establishing its US headquarters and a new hub within the Greater Boston area.
-
Ingrid Scheffer Structural
Ingrid Scheffer serves as the lead investigator for a clinical program associated with Lundbeck.
-
FDA Structural
The FDA granted Orphan Drug Designation to a product of Lundbeck, establishing a formal regulatory dependency for market approval.
-
Food and Drug Administration Structural
The FDA granted Fast Track designation to a product developed by Lundbeck.
-
European Commission Structural
The European Commission regulates Lundbeck by granting specific product designations, such as orphan designation.
-
Johan Luthman Structural
Johan Luthman serves as the Executive Vice President and Head of Research & Development at Lundbeck.
-
European Academy of Neurology Mentioned together
Lundbeck utilized the EAN Congress platform to present new clinical data.
Show all 12 connections
-
Cambridge Shared context
Lundbeck operates within the geographic and regulatory context of Cambridge, Massachusetts.
-
Illinois Structural
Lundbeck established its business roots and operational presence within Illinois.
-
Chicago Shared context
Lundbeck is conducting business activities, including studies and meetings, within the geographical boundaries of Chicago.
-
Athens Shared context
Lundbeck is utilizing Athens as the location for presenting data at the European Epilepsy Congress.